LNC Therapeutics' Series B Round

LNC Therapeutics raised a round of funding on April 10, 2012.

LNC Therapeutics, fka Nutrition Laboratories & Cardio, develops gut microbiota directed drugs to tackle obesity and its associated cardiometabolic diseases.…

Articles about LNC Therapeutics' Series B Round: